PharmaNet Development Group, Inc. Pursues Strategic Alternatives, Possible Sale

Troubled contract research organization (CRO) PharmaNet Development Group announced Thursday that it is working with a financial advisor from USB Investment Bank to explore strategic alternatives, including the potential sale of the company.

MORE ON THIS TOPIC